GI Engineering Solutions Rights Issue 2023 vs Piramal Pharma Rights Issue 2023

Comparison between GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023. GI Engineering Solutions Rights Issue 2023 is listed on BSE, NSE while Piramal Pharma Rights Issue 2023 is listed on BSE, NSE.

 GI Engineering Solutions LimitedPiramal Pharma Limited
LogoGI Engineering Solutions Rights Issue 2023 LogoPiramal Pharma Rights Issue 2023 Logo
Listing AtBSE, NSEBSE, NSE
Terms of PaymentFull Amount on ApplicationFull Amount on Application
Entitlement11 Rights Equity Share(s) for every 8 fully paid-up Equity Shares held on Record Date5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarBigshare Services Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead ManagersICICI Securities Ltd.

Rights Issue Size and Price

The issue size of GI Engineering Solutions Rights Issue 2023 rights issue is ₹49.86 Crores, whereas Piramal Pharma Rights Issue 2023 rights issue size is ₹1,050.00 Crores.

 GI Engineering Solutions LimitedPiramal Pharma Limited
Issue Size4,98,60,082 shares12,96,29,630 shares
Issue Size (Amount)₹49.86 Crores₹1,050.00 Crores
Issue Price₹10 per share₹81 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of GI Engineering Solutions Rights Issue 2023 is Apr 18, 2023 while record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023.

Financials details

Comparison of GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 GI Engineering Solutions LimitedPiramal Pharma Limited
Financial
GI Engineering Solutions Limited Financial Information (Restated Standalone)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-1814.240.020.09
31-Mar-198.280.05-0.08
31-Mar-209.160.12-0.04
31-Mar-214.590.20-2.52
31-Mar-224.440.110.01
Amount in ₹ Crore
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore

Compare with others

Compare:

GI Engineering Solutions Rights Issue 2023 Vs Piramal Pharma Rights Issue 2023